Evidence map›Paper›PMID 19109171›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

Influence of B cell antigen receptor expression level on pathways of B cell tolerance induction.

Xiaohe Liu, Shixue Shen, Tim Manser

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Antigen-specific suppression of humoral immunity by anergic Ars/A1 B cells.Journal of immunology (Baltimore, Md. : 1950) · 2012
    Article
  5. Article
  6. Article
  7. Article
  8. B cell receptor editing in tolerance and autoimmunity.Annals of the New York Academy of Sciences · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Xiaohe LiuDepartment of Microbiology and Immunology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Shixue Shen
Tim Manser
Thomas Jefferson University · US

Funding

Negative Selective of Autoreactive AntibodiesR01AI038965 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI MANSER, TIMOTHY L · 1996 to 2011
$3.2M
Negative selection of autoreactive antibodiesR56AI038965 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI MANSER, TIMOTHY L · 2012 to 2012
$388k
NIAID NIH HHS AI038965NIAID NIH HHS R01 AI038965NIAID NIH HHS R56 AI038965
6 · The paper itself

Abstract

We have described an Ig-transgenic, autoreactive B cell clonotype that undergoes a novel tolerance pathway. Early in development this clonotype expresses average BCR levels, but these levels are progressively down-regulated as development proceeds efficiently to the mature, follicular compartment. This clonotype does not display conventional features of anergy and can be induced to undergo apoptosis and receptor editing in in vitro bone marrow cultures, but these pathways are not taken in vivo. These data suggested that autoantigen-driven down-regulation of BCR levels and, hence, avidity for autoantigen allows this clonotype to bypass conventional tolerance mechanisms. To test this idea, we enforced elevated levels of expression of BCR in this clonotype by making the transgenic Igh locus homozygous. This resulted in retarded clonotype development and L chain receptor editing in vivo. These data support a pivotal role for adaptive, autoantigen-induced adjustment of BCR expression levels in the regulation of primary B cell development and tolerance.

Indexed as

Immune ToleranceAnimalsAntibodies, AntinuclearAutoantigensB-Lymphocyte SubsetsCell AdhesionCell DifferentiationCell LineCells, CulturedDown-RegulationGrowth InhibitorsImmunoglobulin Heavy ChainsMiceMice, Inbred C57BLMice, TransgenicReceptors, Antigen, B-CellAntibodies, AntinuclearAutoantigensGrowth InhibitorsImmunoglobulin Heavy ChainsReceptors, Antigen, B-Cell

Identifiers

PMID19109171
PMCPMC6541383
OpenAlexW2134937320

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.